The effects of alloying elements on the microstructural factors, hardness, and wear properties of four high-speed steel (HSS) rolls fabricated by centrifugal casting were investigated. A hot-rolling simulation test was carried out using a high-temperature wear tester capable of controlling speed, load, and temperature. The test results revealed that the HSS roll containing a larger amount of vanadium showed the best wear resistance because it contained a number of hard MC-type carbides. However, it showed a very rough roll surface because of cracking along cell boundaries, the preferential removal of the matrix, and the sticking of the rolled material onto the roll surface during the wear process, thereby leading to an increase in the friction coefficient and rolling force. In order to improve wear resistance with consideration to surface roughness, it is suggested that a reduction in the vanadium content, an increase in solid-solution hardening by adding alloying elements, an increase in secondary hardening by precipitation of fine carbides in the matrix, and formation of refined prior austenite grains by preaustenitization treatment be employed to strengthen the matrix, which can hold hard carbides in it.
The effects of tempering temperature on wear resistance and surface roughness of a high speed steel (HSS) roll manufactured by centrifugal casting method were investigated in this study. Hot-rolling simulation test was carried out using a high-temperature wear tester capable of controlling speed, load, and temperature. The test results revealed that the peak-tempered roll specimen showed the best wear resistance because of its hard matrix. However, its surface roughness deteriorated as the scratching wear proceeded, thereby leading to increase in friction coefficient. In the over-tempered specimens containing numerous fine spherical carbides in the matrix, the abrasive wear occurred predominantly as fine carbides were fallen off from the matrix, and thus the surface roughness was enhanced by the homogeneous wear of both matrix and carbides. These findings suggested that the tempering treatment at temperatures slightly past the peak hardness point would be more desirable in order to improve the wear resistance with consideration of the surface roughness of the HSS roll.
BackgroundHuman papillomavirus (HPV) is known to cause of oropharyngeal squamous cell carcinoma (SqCC). HPV positive SqCCs overexpress p16 and are associated with better survival. Several markers of cell cycles and apoptosis have been reported as a prognostic value. We examined the prognostic value of HPV status, p16, cyclin D1, and Bcl-2 in patients with tonsillar SqCC.MethodsTissue microarrays were constructed in 56 cases of tonsillar SqCC for which we performed an immunohistochemistry and an in situ hybridization (ISH) of the HPV.ResultsOf the 56 cases, 31 (55.3%) were positive for p16 and 20 (35.7%) were positive for HPV ISH. The expressions of p16, cyclin D1, and Bcl-2 were not correlated with the clinicopathologic variables including smoking status, differentiation and pT- and pN-stages. The HPV ISH positive group showed a better overall survival than the HPV negative group (p=0.04), and the p16 positive group showed a better disease free survival (DFS) than the negative group (p=0.016). Cox regression analysis showed that only p16 positivity was an independent prognostic factor for DFS (p=0.03; hazard ratio, 10.1).ConclusionsOur results indicate that both p16 expression and HPV status are useful indicators for risk stratification in patients with tonsillar SqCC.
The aim of this study was to introduce the implemented MEDBIZ platform based on the internet of medical things (IoMT) supporting real-time digital health services for precision medicine. In addition, we demonstrated four empirical studies of the digital health ecosystem that could provide real-time healthcare services based on IoMT using real-world data from in-hospital and out-hospital patients. Implemented MEDBIZ platform based on the IoMT devices and big data to provide digital healthcare services to the enterprise and users. The big data platform is consisting of four main components: IoMT, core, analytics, and services. Among the implemented MEDBIZ platform, we performed four clinical trials that designed monitoring services related to chronic obstructive pulmonary disease, metabolic syndrome, arrhythmia, and diabetes mellitus. Of the four empirical studies on monitoring services, two had been completed and the rest were still in progress. In the metabolic syndrome monitoring service, two studies were reported. One was reported that intervention components, especially wearable devices and mobile apps, made systolic blood pressure, diastolic blood pressure, waist circumference, and glycosylated hemoglobin decrease after 6 months. Another one was presented that increasing high-density lipoprotein cholesterol and triglyceride levels were prevented in participants with the pre-metabolic syndrome. Also, self-care using healthcare devices might help prevent and manage metabolic syndrome. In the arrhythmia monitoring service, during the real-time monitoring of vital signs remotely at the monitoring center, 318 (15.9%) general hikers found abnormal signals, and 296 (93.1%) people were recommended for treatment. We demonstrated the implemented MEDBIZ platform based on IoMT supporting digital healthcare services by acquiring real-world data for getting real-world evidence. And then through this platform, we were developing software as a medical device, digital therapeutics, and digital healthcare services, and contributing to the development of the digital health ecosystem.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.